GlassScriptPhysician profile
Katherine Taylor
NPI 1669846705
$525.34
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $317 · 2022: $68.60 · 2023: $115 · 2024: $24.24.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $139.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $139.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $127.77 | 2022-2023 | Otezla |
| Astrazeneca Pharmaceuticals LP | $99.95 | 2021 | |
| Astellas Pharma US INC | $75.00 | 2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $68.52 | 2021 | |
| Esperion Therapeutics, INC. | $47.99 | 2021 | |
| Glaxosmithkline, LLC. | $26.02 | 2021 | |
| Incyte Corporation | $24.24 | 2024 | Opzelura |
| Novo Nordisk INC | $21.21 | 2022 | |
| Sanofi-Aventis U.S. LLC | $18.80 | 2022 | |
| Novartis Pharmaceuticals Corporation | $15.84 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.